Cargando…
Potential molecular targets for Ewing's sarcoma therapy
Ewing's sarcoma (ES) is a highly malignant tumor of children and young adults. Modern therapy for Ewing's sarcoma combines high-dose chemotherapy for systemic control of disease, with advanced surgical and/or radiation therapeutic approaches for local control. Despite optimal management, t...
Autores principales: | Jully, Babu, Rajkumar, Thangarajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618640/ https://www.ncbi.nlm.nih.gov/pubmed/23580819 http://dx.doi.org/10.4103/0971-5851.107074 |
Ejemplares similares
-
Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing’s Sarcoma in vitro
por: Jully, Babu, et al.
Publicado: (2012) -
Targeted Therapy in Ewing Sarcoma
por: Lissat, A., et al.
Publicado: (2012) -
Targeted Therapy of Ewing's Sarcoma
por: Subbiah, Vivek, et al.
Publicado: (2011) -
Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016) -
A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins
por: Thangaretnam, Krishna Priya, et al.
Publicado: (2017)